122 related articles for article (PubMed ID: 21549736)
41. A modified double-emulsion method for the preparation of daunorubicin-loaded polymeric nanoparticle with enhanced in vitro anti-tumor activity.
Liu J; Qiu Z; Wang S; Zhou L; Zhang S
Biomed Mater; 2010 Dec; 5(6):065002. PubMed ID: 20924138
[TBL] [Abstract][Full Text] [Related]
42. Thermally sensitive micelles self-assembled from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) for controlled delivery of paclitaxel.
Liu SQ; Tong YW; Yang YY
Mol Biosyst; 2005 Jul; 1(2):158-65. PubMed ID: 16880979
[TBL] [Abstract][Full Text] [Related]
43. Clathrin and caveolin-1 expression in primary pigmented rabbit conjunctival epithelial cells: role in PLGA nanoparticle endocytosis.
Qaddoumi MG; Gukasyan HJ; Davda J; Labhasetwar V; Kim KJ; Lee VH
Mol Vis; 2003 Oct; 9():559-68. PubMed ID: 14566223
[TBL] [Abstract][Full Text] [Related]
44. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting.
Chung YI; Kim JC; Kim YH; Tae G; Lee SY; Kim K; Kwon IC
J Control Release; 2010 May; 143(3):374-82. PubMed ID: 20109508
[TBL] [Abstract][Full Text] [Related]
45. Study of intracellular delivery of doxorubicin from poly(lactide-co-glycolide) nanoparticles by means of fluorescence lifetime imaging and confocal Raman microscopy.
Romero G; Qiu Y; Murray RA; Moya SE
Macromol Biosci; 2013 Feb; 13(2):234-41. PubMed ID: 23316003
[TBL] [Abstract][Full Text] [Related]
46. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
[TBL] [Abstract][Full Text] [Related]
47. In-vivo tumor targeting of pluronic-based nano-carriers.
Kim JY; Choi WI; Kim YH; Tae G; Lee SY; Kim K; Kwon IC
J Control Release; 2010 Oct; 147(1):109-17. PubMed ID: 20600404
[TBL] [Abstract][Full Text] [Related]
48. Distribution and deposition of respirable PLGA microspheres in lung alveoli.
Hirota K; Kawamoto T; Nakajima T; Makino K; Terada H
Colloids Surf B Biointerfaces; 2013 May; 105():92-7. PubMed ID: 23384687
[TBL] [Abstract][Full Text] [Related]
49. Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity.
Hamdy S; Molavi O; Ma Z; Haddadi A; Alshamsan A; Gobti Z; Elhasi S; Samuel J; Lavasanifar A
Vaccine; 2008 Sep; 26(39):5046-57. PubMed ID: 18680779
[TBL] [Abstract][Full Text] [Related]
50. Preparation and characterization of cationic chitosan-modified poly(D,L-lactide-co-glycolide) copolymer nanospheres as DNA carriers.
Guan XP; Quan DP; Liao KR; Tao Wang ; Peng Xiang ; Mai KC
J Biomater Appl; 2008 Jan; 22(4):353-71. PubMed ID: 17494965
[TBL] [Abstract][Full Text] [Related]
51. DNA binding, cytotoxicity, and apoptotic-inducing activity of ruthenium(II) polypyridyl complex.
Zhang P; Chen J; Liang Y
Acta Biochim Biophys Sin (Shanghai); 2010 Jul; 42(7):440-9. PubMed ID: 20705582
[TBL] [Abstract][Full Text] [Related]
52. PLGA-dendron nanoparticles enhance immunogenicity but not lethal antibody production of a DNA vaccine against anthrax in mice.
Ribeiro S; Rijpkema SG; Durrani Z; Florence AT
Int J Pharm; 2007 Mar; 331(2):228-32. PubMed ID: 17258876
[TBL] [Abstract][Full Text] [Related]
53. Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures.
Costantino L; Gandolfi F; Bossy-Nobs L; Tosi G; Gurny R; Rivasi F; Vandelli MA; Forni F
Biomaterials; 2006 Sep; 27(26):4635-45. PubMed ID: 16716395
[TBL] [Abstract][Full Text] [Related]
54. Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice.
Bivas-Benita M; Lin MY; Bal SM; van Meijgaarden KE; Franken KL; Friggen AH; Junginger HE; Borchard G; Klein MR; Ottenhoff TH
Vaccine; 2009 Jun; 27(30):4010-7. PubMed ID: 19389445
[TBL] [Abstract][Full Text] [Related]
55. Development and evaluation of novel biodegradable microspheres based on poly(d,l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies.
Mundargi RC; Srirangarajan S; Agnihotri SA; Patil SA; Ravindra S; Setty SB; Aminabhavi TM
J Control Release; 2007 May; 119(1):59-68. PubMed ID: 17331611
[TBL] [Abstract][Full Text] [Related]
56. In vitro anti-tumour and cyto-selective effects of coumarin-3-carboxylic acid and three of its hydroxylated derivatives, along with their silver-based complexes, using human epithelial carcinoma cell lines.
Thati B; Noble A; Creaven BS; Walsh M; McCann M; Kavanagh K; Devereux M; Egan DA
Cancer Lett; 2007 Apr; 248(2):321-31. PubMed ID: 16996681
[TBL] [Abstract][Full Text] [Related]
57. Curcumin-loaded PLGA-PEG-PLGA triblock copolymeric micelles: Preparation, pharmacokinetics and distribution in vivo.
Song Z; Feng R; Sun M; Guo C; Gao Y; Li L; Zhai G
J Colloid Interface Sci; 2011 Feb; 354(1):116-23. PubMed ID: 21044788
[TBL] [Abstract][Full Text] [Related]
58. In vitro study of anticancer drug doxorubicin in PLGA-based microparticles.
Lin R; Shi Ng L; Wang CH
Biomaterials; 2005 Jul; 26(21):4476-85. PubMed ID: 15701377
[TBL] [Abstract][Full Text] [Related]
59. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs.
Win KY; Feng SS
Biomaterials; 2005 May; 26(15):2713-22. PubMed ID: 15585275
[TBL] [Abstract][Full Text] [Related]
60. Ameliorative effects of Syzygium jambolanum extract and its poly (lactic-co-glycolic) acid nano-encapsulated form on arsenic-induced hyperglycemic stress: a multi-parametric evaluation.
Samadder A; Das S; Das J; Paul A; Khuda-Bukhsh AR
J Acupunct Meridian Stud; 2012 Dec; 5(6):310-8. PubMed ID: 23265083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
